3rd Edition of World Congress on Endocrinology, Diabetes and Metabolism


The theme: “Trending Research Innovations and Insights into Endocrinology, Diabetes & Metabolism”

On the agenda:

  • Hospital readmission of people with diabetes: Can we identify those at risk?
  • Primary hypothyroidism and autoimmune thyroiditis affect the expression of mRNA in nerve impulse transmission genes in patients' blood
  • Secretory autophagy and its relevance in metabolic and degenerative disease
  • Type 2 DM: Gender influence in nitrogen metabolism and the regulation of levels of HGF and EGF by insulin/glucagon ratio
  • Vascular calcification impairs bone metabolism
  • Adrenal masses and testicular adrenal rest tumors (TARTs) in classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) in adult males
  • Hypertension and its related factors among patients with type 2 diabetes mellitus – a multi-hospital study in Bangladesh
  • Improvements in thyroid in-vitro diagnostics
  • Long-term exercises increase the taste sensitivity for sucrose and reduces the carbohydrate intake and anthropometric parameters in patients with type 2 diabetes mellitus
  • Genetic drivers of ileal neuroendocrine tumors
  • Enlarged adipocytes from subcutaneous vs visceral adipose tissue diferentially contribute to metabolic dysfunction and atherogenic risk of patients with obesity
  • Advancing towards mitochondrial understanding of thyroid disease – the importance of glycolysis Puberty suppression with GnRH analogues in adolescents with gender incongruity
  • Self-management behavior and fasting plasma glucose control in patients with type 2 diabetes mellitus over 60 years old: Multiple effects of social support on quality of life
  • Serum uric acid concentration is associated with insulin resistance and impaired insulin secretion in adults at risk for type 2 diabetes
and more
Venue: Radisson Hotel & Conference Centre London Heathrow


October 4-5, 2022


West Drayton, United Kingdom